TRIP13 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance
Normal-vs-Primary 2.045200E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Stage1
3.441600E-01
Normal-vs-Stage2
5.89619999999957E-05
Normal-vs-Stage3
2.579200E-01
Normal-vs-Stage4
4.653600E-01
Stage1-vs-Stage2
3.663400E-01
Stage1-vs-Stage3
4.843400E-01
Stage1-vs-Stage4
6.471600E-01
Stage2-vs-Stage3
9.229800E-01
Stage2-vs-Stage4
3.085600E-01
Stage3-vs-Stage4
3.753200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Caucasian
9.91359999999997E-05
Normal-vs-AfricanAmerican
2.948800E-01
Normal-vs-Asian
8.860400E-02
Caucasian-vs-AfricanAmerican
9.262400E-01
Caucasian-vs-Asian
7.081200E-01
AfricanAmerican-vs-Asian
9.588400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Male
1.698640E-01
Normal-vs-Female
3.71630000000067E-05
Male-vs-Female
3.279800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Age(21-40Yrs)
7.393200E-01
Normal-vs-Age(41-60Yrs)
1.164240E-04
Normal-vs-Age(61-80Yrs)
1.864420E-01
Normal-vs-Age(81-100Yrs)
2.729800E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.708800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.885800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.300800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.648200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.092000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.837800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Non Drinker
4.258600E-03
Normal-vs-Daily Drinker
1.119880E-03
Normal-vs-Weekly Drinker
5.464200E-02
Normal-vs-Occasional Drinker
6.384800E-03
Normal-vs-Social Drinker
1.719250E-03
Non Drinker-vs-Daily Drinker
6.549600E-01
Non Drinker-vs-Weekly Drinker
2.923400E-01
Non Drinker-vs-Occasional Drinker
6.172800E-01
Non Drinker-vs-Social Drinker
3.598800E-01
Daily Drinker-vs-Weekly Drinker
3.773200E-01
Daily Drinker-vs-Occasional Drinker
9.146400E-01
Daily Drinker-vs-Social Drinker
5.794600E-01
Weekly Drinker-vs-Occasional Drinker
4.143000E-01
Weekly Drinker-vs-Social Drinker
5.250800E-01
Occasional Drinker-vs-Social Drinker
6.992200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions
Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade)
Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Grade 1
5.556600E-01
Normal-vs-Grade 2
5.760400E-01
Normal-vs-Grade 3
5.998800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.928300E-02
Grade 1-vs-Grade 3
1.616290E-02
Grade 1-vs-Grade 4
5.556600E-01
Grade 2-vs-Grade 3
1.033210E-01
Grade 2-vs-Grade 4
5.760400E-01
Grade 3-vs-Grade 4
5.998800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Diabetic
8.116000E-03
Normal-vs-NonDiabetic
1.69754000000077E-05
Diabetic-vs-NonDiabetic
9.987700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Pancreatitis
3.364600E-03
Normal-vs-NoPancreatitis
7.98880000000279E-05
Pancreatitis-vs-NoPancreatitis
3.430800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions
N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes
N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-N0
1.632970E-01
Normal-vs-N1
3.8219000000006E-05
N0-vs-N1
4.333800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-TP53-Mutant
1.29440003160397E-09
Normal-vs-TP53-NonMutant
5.384700E-04
TP53-Mutant-vs-TP53-NonMutant
2.06170000000006E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap